Vyxeos® With Clofarabine for Pediatric AML

Clinical trial NCT07156435 · RECRUITING

Trial details

NCT number: NCT07156435
Sponsor: Princess Maxima Center for Pediatric Oncology
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed Pediatric AML Refractory Pediatric AML

Start date: 2020-11-06
Primary completion: 2026-12-31
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.